CLINICAL_TRIALS
trial_result
· 2025-06-11
Clinical Trial Update: Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction. [Phase 4]
Summary
A Phase 4 trial evaluates whether hydration can prevent contrast-induced nephropathy during percutaneous intervention for ST-elevation myocardial infarction.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Contrast Induced Nephropathy | Phase 4 | Status: COMPLETED